Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Public-interest Multicenter Umbrella Trial Based on Genetic Analysis in Korean Head and Neck Cancer and Esophageal Cancer Patient - Part 1 (HNSCC)]

X
Trial Profile

Public-interest Multicenter Umbrella Trial Based on Genetic Analysis in Korean Head and Neck Cancer and Esophageal Cancer Patient - Part 1 (HNSCC)]

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Abemaciclib (Primary) ; Alpelisib (Primary) ; Durvalumab (Primary) ; Nintedanib (Primary) ; Poziotinib (Primary) ; Tremelimumab (Primary)
  • Indications Head and neck cancer; Oesophageal cancer; Squamous cell cancer
  • Focus Biomarker; Therapeutic Use
  • Acronyms KCSG HN 15-16 TRIUMPH Trial; TRIUMPH
  • Most Recent Events

    • 12 Sep 2023 Results reporting safety and efficacy data over 12 months published in the Journal of Clinical Oncology
    • 27 Mar 2022 Status changed from recruiting to completed.
    • 05 Jun 2018 Results (n=93) presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top